These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29673070)
1. MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3. Kong D; Zhao L; Sun L; Fan S; Li H; Zhao Y; Guo Z; Lin L; Cui L; Wang K; Chen W; Zhang Y; Zhou J; Li Y J Cell Mol Med; 2018 Jul; 22(7):3627-3637. PubMed ID: 29673070 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL. Zhao L; Lv C; Sun L; Li Q; Wang Y; Wu M; Wang Y; Guo Z; Bian S; Kong D; Lin L; Wang Y; Zhou J; Li Y Invest New Drugs; 2021 Aug; 39(4):961-970. PubMed ID: 33566253 [TBL] [Abstract][Full Text] [Related]
3. Study on the role of MYCN in retinoblastoma by inhibiting p53 and activating wnt/βcatenin/Fra-1 signaling pathway by reducing DKK3. Chen X; Ouyang L; Ke N; Pi L; Zhou X Drug Dev Res; 2024 Aug; 85(5):e22222. PubMed ID: 39003564 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibition and suppression of the mTOR and Wnt/β-catenin pathways in T-acute lymphoblastic leukemia by rapamycin and MYCN depletion. Kong D; Fan S; Sun L; Chen X; Zhao Y; Zhao L; Guo Z; Li Y Hematol Oncol; 2021 Apr; 39(2):222-230. PubMed ID: 33300153 [TBL] [Abstract][Full Text] [Related]
5. Suppression of miR-708 inhibits the Wnt/β-catenin signaling pathway by activating DKK3 in adult B-all. Zhang Y; Li H; Cao R; Sun L; Wang Y; Fan S; Zhao Y; Kong D; Cui L; Lin L; Wang K; Li Y; Zhou J Oncotarget; 2017 Sep; 8(38):64114-64128. PubMed ID: 28969056 [TBL] [Abstract][Full Text] [Related]
6. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation. Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690 [No Abstract] [Full Text] [Related]
7. Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells. Xiang T; Li L; Yin X; Zhong L; Peng W; Qiu Z; Ren G; Tao Q J Cell Mol Med; 2013 Oct; 17(10):1236-46. PubMed ID: 23890219 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway. Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066 [TBL] [Abstract][Full Text] [Related]
10. KDM1A drives hepatoblastoma progression by activating the Wnt/β-catenin pathway through inhibition of DKK3 transcription. Ji C; Chen L; Yuan M; Xie W; Sheng X; Yin Q Tissue Cell; 2023 Apr; 81():101989. PubMed ID: 36642006 [TBL] [Abstract][Full Text] [Related]
11. Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3. Shailesh H; Siveen KS; Sif S J Cell Mol Med; 2021 Feb; 25(3):1583-1600. PubMed ID: 33462997 [TBL] [Abstract][Full Text] [Related]
12. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Koppen A; Ait-Aissa R; Koster J; Øra I; Bras J; van Sluis PG; Caron H; Versteeg R; Valentijn LJ Int J Cancer; 2008 Apr; 122(7):1455-64. PubMed ID: 18059033 [TBL] [Abstract][Full Text] [Related]
13. DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner. Song J; Chen Y; Chen Y; Qiu M; Xiang W; Ke B; Fang X Ren Fail; 2024 Dec; 46(1):2343817. PubMed ID: 38682264 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of Dkk3 activates beta-catenin/TCF-4 signaling in lung cancer. Yue W; Sun Q; Dacic S; Landreneau RJ; Siegfried JM; Yu J; Zhang L Carcinogenesis; 2008 Jan; 29(1):84-92. PubMed ID: 18048388 [TBL] [Abstract][Full Text] [Related]
15. Wnt signalling is a bi-directional vulnerability of cancer cells. Duffy DJ; Krstic A; Schwarzl T; Halasz M; Iljin K; Fey D; Haley B; Whilde J; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W Oncotarget; 2016 Sep; 7(37):60310-60331. PubMed ID: 27531891 [TBL] [Abstract][Full Text] [Related]
16. Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway. Huo J; Zhang Y; Li R; Wang Y; Wu J; Zhang D Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801786 [TBL] [Abstract][Full Text] [Related]
17. lnc‑MICAL2‑1 sponges miR‑25 to regulate DKK3 expression and inhibits activation of the Wnt/β‑catenin signaling pathway in breast cancer. Yao J; Li G; Liu M; Yang S; Su H; Ye C Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34970696 [TBL] [Abstract][Full Text] [Related]
18. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC. Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685 [TBL] [Abstract][Full Text] [Related]
19. Effect of miR-25 on Proliferation of Nasopharyngeal Carcinoma Cells through Wnt/ He H; Yuan K; Chen W Biomed Res Int; 2021; 2021():9957161. PubMed ID: 34485531 [TBL] [Abstract][Full Text] [Related]
20. Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma. De Brouwer S; Mestdagh P; Lambertz I; Pattyn F; De Paepe A; Westermann F; Schroeder C; Schulte JH; Schramm A; De Preter K; Vandesompele J; Speleman F Int J Cancer; 2012 Jun; 130(11):2591-8. PubMed ID: 21796614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]